The science and data really matter.As Robert said, “no one wants the second best cancer cure”. The money in biotech ventures are much greater, and the science has to be there to justify the investment. The technology should be tested and proven, the science vetted by experts. If it’s a therapeutic — are there indicators that it could work in humans?
https://medium.com/@Deanna.Loh/an-hour-with-robert-nelson-co-founder-of-arch-venture-partners-9166fb998ac3
Itsa: This is why I’m not worried about getting $70/$100 million before Futility…
Science and Robust data = $$$$$
For General Information, page-1065
Add PER (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $69.41M | |||
| Open | High | Low | Value | Volume |
| 7.9¢ | 7.9¢ | 7.6¢ | $26.62K | 343.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 113467 | 7.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.7¢ | 98248 | 1 |
View Market Depth
| Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
|
Last
7.7¢ |
Change
0.000 ( 1.28 %) |
||||
| Open | High | Low | Volume | ||
| 7.9¢ | 7.9¢ | 7.7¢ | 14800 | ||
| Last updated 15.52pm 06/05/2024 ? | |||||
| PER (ASX) Chart |